Senolytic Therapy: A Potential Approach for the Elimination of Oncogene-Induced Senescent HPV-Positive Cells

Area of Science:

• Cellular Biology
• Oncology
• Virology

Background:

• Senescence is a cellular stress response causing growth arrest, often a tumor-suppressive mechanism.
• Oncogene activation (e.g., H-Ras) and Human Papilloma Virus (HPV) can induce senescence.
• Current HPV vaccines are ineffective against existing HPV infections, necessitating alternative cancer prevention strategies.

Purpose of the Study:

• To discuss the role of oncogene and HPV-induced senescence (OIS) in cervical cancer development.
• To explore the therapeutic potential of senolytic agents in eliminating HPV-harboring senescent cells.
• To propose senolytics as a strategy to reduce HPV-driven cervical cancer risk.

Main Methods:

• Review of existing literature on cellular senescence, oncogenesis, and HPV.
• Analysis of mechanisms by which oncogenes and HPV induce senescence.
• Evaluation of senolytic agents' potential to target senescent cells in the context of cervical cancer.

Main Results:

• Senescence acts as a tumor suppressor by halting the proliferation of cells with oncogenic mutations or viral infections.
• High-risk HPV strains can evade or manipulate senescence pathways, contributing to cervical cell transformation.
• Senescent cells accumulate in premalignant lesions, presenting a potential therapeutic target.

Conclusions:

• Targeting oncogene and HPV-induced senescence (OIS) is a promising avenue for cervical cancer prevention.
• Senolytic agents may eliminate HPV-infected senescent cells, reducing cancer development risk.
• Further research into senolytics could lead to novel strategies for managing HPV-positive individuals.